Long COVID study: Walking
Official title Heat thErapy And mobiLity in COVID-19 Survivors
ClinicalTrials.gov ID: NCT06928116
What this study is testing
- What it's testing
- The study aims to see if heat therapy is safe and can improve functional capacity, metabolic and vascular health in people with long COVID.
- Who it's for
- Adults in late‑middle age or older who have long COVID.
- What's involved
- Participants will use a heat therapy device at home for lower‑body treatment. The study will monitor their functional capacity and health markers.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 90
You may be able to join if
- Between the ages of 50 and 90 years
- Free from orthopedic limitations that would prohibit performing leg exercise
- BMI \< 40 kg/m2 and weigh \< 400lbs
- Previously contracted Covid-19 and have persistent symptoms such as a fatigue or decline in physical function, for at least 2 months following...
You likely can't join if
- Unable to give written informed consent
- Women who are pregnant, breastfeeding, or likely to become pregnant within the next 6 months
- Claustrophobia
- Orthopedic limitations that would prohibit them from walking
- Currently enrolled in an exercise-based or respiratory muscle rehabilitation program.
The study team makes the final eligibility decision.
Where it is enrolling
- Omaha, Nebraska, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Omaha, Nebraska, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.